Drug Type Small molecule drug |
Synonyms- |
Target |
Action agonists |
Mechanism RXRs agonists(Retinoid X receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC20H14O7 |
InChIKeyBCLNKNUUTUITEA-UHFFFAOYSA-N |
CAS Registry3749-38-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metabolic Diseases | Preclinical | Japan | 07 Mar 2025 | |
Neoplasms | Preclinical | Japan | 07 Mar 2025 |